15:30am Chair Introduction 

Chairperson: Paula Pulsoni, Vice President, Sales and Services, WorldCourier 

15:35am Presentation: Cold Chain Excellence: CMC Strategies for Streamlining Global Logistics of Cryopreserved Cell Therapy Products

• Challenges and best practices in the international transportation of cellular medicines; 
• Implementing effective distribution strategies for the global supply of cell therapy products to improve patient access. 

Ben Weil, Director of Manufacturing, INmune Bio   

15:50am Presentation: Looking to the Future: ​The Evolving CGT Supply Chain Paradigm

Robert Jones, Vice President, Global Bioservices, Cryoport 

16:05am Presentation: Paving the Way for Global Cryologistics with the Help of Product and Process Knowledge – Lessons Learned from Two Global Phase 3 Trials.

• The importance of logistical needs and product data generation during early product and process development, for successful global deployment.  
• The effect of the cells journey from the manufacturing facility and up to the patient on the product quality and how to create the design space. 
• The importance of internal and external collaborations for the successful deployment of cryopreserved cell products. 

Lior Raviv, Chief Technology Officer, Pluri  

16:20am Presentation: Addressing Logistical Challenges – How Albumin Can Improve the Storage and Stability of Cells 

• Protect against loss of live cells numbers and cell viability post-thaw with reduced DSMO conc. 
• Increase hold time and reduce the number of apoptotic cells post thaw. 
• Your choice of albumin matters; different albumin sources and formulations 

Philip Morton, Chief Technology Officer, Albumedix

16:35pm Closing Panel with Q&A  

With all session participants